Lobelane Analogues as Novel Ligands for the Vesicular Monoamine Transporter-2

Bioorganic and Medicinal Chemistry- United Kingdom

doi 10.1016/j.bmc.2005.04.013

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Defunctionalized Lobeline Analogues: Structure−Activity of Novel Ligands for the Vesicular Monoamine Transporter

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2005English

GZ-793A, a Lobelane Analog, Interacts With the Vesicular Monoamine Transporter-2 to Inhibit the Effect of Methamphetamine

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2013English

Ephedrine Decreases Vesicular Monoamine Transporter-2 Function

Synapse
Molecular NeuroscienceCellular
2011Italian

The Vesicular Monoamine Transporter 2: An Underexplored Pharmacological Target

Neurochemistry International
Molecular NeuroscienceCell BiologyCellular
2014English

A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2

PLoS ONE
Multidisciplinary
2016English

Genetic Variation in the Vesicular Monoamine Transporter

Journal of Head Trauma Rehabilitation
Physical TherapySports TherapyNeurologyRehabilitation
2017English

Preclinical Efficacy of Novel Vesicular Monoamine Transporter 2 Inhibitors as Antagonists of D-Methamphetamine Self-Administration in Rats

Journal of Alcoholism & Drug Dependence
2015English

Characterization of [11C]tetrabenazine as an in Vivo Radioligand for the Vesicular Monoamine Transporter

Nuclear Medicine and Biology
Cancer ResearchNuclear MedicineRadiologyMolecular MedicineImaging
1994English

Therapeutic Doses of Amphetamine and Methylphenidate Selectively Redistribute the Vesicular Monoamine Transporter-2

European Journal of Pharmacology
Pharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy